Cargando…
Factors Influencing the One- and Two-Year Growth Response in Children Treated with Growth Hormone: Analysis from an Observational Study
To assess gender-, pubertal-, age-related differences in change from baseline height standard deviation score (ΔHSDS), data from 5,797 growth hormone (GH) naïve pediatric patients (<18 years) with growth hormone deficiency (GHD), multiple pituitary hormone deficiency (MPHD), Turner syndrome (TS),...
Autores principales: | Ross, Judith, Lee, Peter A., Gut, Robert, Germak, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957130/ https://www.ncbi.nlm.nih.gov/pubmed/20981140 http://dx.doi.org/10.1155/2010/494656 |
Ejemplares similares
-
Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry
por: Lee, Peter A, et al.
Publicado: (2012) -
Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program(®)
por: Lee, Peter A, et al.
Publicado: (2011) -
Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Program
por: Ross, Judith L, et al.
Publicado: (2015) -
Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program
por: Lee, Peter A., et al.
Publicado: (2015) -
Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations
por: Cohen, Pinchas, et al.
Publicado: (2014)